Part 3: Case-Based Management of Scabies
Scabies is a nondiscriminatory, widespread disease that affects about 3% of the world population at any given time. In Part 3 of this educational video series, Dr. Christopher Belcher discusses the safety, efficacy of Natroba (Spinosad) 0.9% topical FDA-approved for the treatment of head lice and scabies.
Part 2: Current Scabies Treatment Paradigms
In Part 2 of this educational video series, Dr. Ted Rosen discusses the diagnosis of and recommended and alternative treatment regimens for scabies, including existing unmet treatment needs.
Part 1: Newly Approved Treatments for Parasitic Skin Infections
Scabies is a nondiscriminatory, widespread disease that affects about 3% of the world population at any given time. In Part 1 of this educational video series on treatments for parasitic skin infections, Ted Rosen, MD, discusses the incidence and prevalence of scabies, emphasizing the importance of timely treatment.